Florian Krammer
Icahn School of Medicine at Mount Sinai
H-index: 107
North America-United States
Top articles of Florian Krammer
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Influenza virus hemagglutinin proteins and uses thereof | 2024/1/9 | ||
Phase II/III Double-Blind Study Evaluating Safety and Immunogenicity of a Single Intramuscular Booster Dose of the Recombinant SARS-CoV-2 Vaccine" Patria"(AVX/COVID-12) Using … | medRxiv | Constantino López-Macías Martha Torres Brenda Armenta-Copca Niels H Wacher Arturo Galindo-Fraga | 2024 |
Profile of Katalin Karikó and Drew Weissman: 2023 Nobel laureates in Physiology or Medicine | Proceedings of the National Academy of Sciences | Florian Krammer Peter Palese | 2024/2/27 |
SARS-CoV-2 BA. 1 and BA. 2 breakthrough infections boost antibody responses to early Omicron subvariants but not BQ. 1.1 or XBB. 1.5 | Cell Reports Medicine | Anass Abbad Temima Yellin Gagandeep Singh Miriam Fried Ariel Raskin | 2024/3/19 |
MICBG406APolymorphism Confers Reduced Risk of Mechanical Ventilation and Death in Patients at Risk for Acute Lung Injury | H Pickering RR Montgomery A Rahman H Maecker S Bosinger | 2024/5 | |
Features of acute COVID-19 associated with post-acute sequelae of SARS-CoV-2 phenotypes: results from the IMPACC study | Nature Communications | Al Ozonoff Naresh Doni Jayavelu Shanshan Liu Esther Melamed Carly E Milliren | 2024/1/3 |
Determinants of health as predictors for differential antibody responses following SARS-CoV-2 primary and booster vaccination in an at-risk, longitudinal cohort | Plos one | E Williams V Testamarck J Carreño D Bielak T Yellin | 2024/1/1 |
SARS-CoV-2-infection-and vaccine-induced antibody responses are long lasting with an initial waning phase followed by a stabilization phase | Immunity | Komal Srivastava Juan Manuel Carreño Charles Gleason Brian Monahan Gagandeep Singh | 2024/2/19 |
A pan-orthohantavirus preclinical human lung xenograft mouse model | Melanie Rissmann Danny Noack Thomas Spliethof Vincent Vaes Rianne Stam | 2024/3/6 | |
Detection of clade 2.3. 4.4 b highly pathogenic H5N1 influenza virus in New York City | bioRxiv | Philip S Meade Pooja Bandawane Kaitlyn Bushfield Irene Hoxie Karla R Azcona | 2024 |
Bat-borne H9N2 influenza virus evades MxA restriction and exhibits efficient replication and transmission in ferrets | Nature Communications | Nico Joel Halwe Lea Hamberger Julia Sehl-Ewert Christin Mache Jacob Schön | 2024/4/25 |
Production of Influenza Virus Glycoproteins Using Insect Cells | Madhumathi Loganathan Benjamin Francis Florian Krammer | 2024/2/6 | |
Is eradication of influenza B viruses possible? | The Lancet. Infectious diseases | Marios Koutsakos Steven Rockman Florian Krammer | 2024/3/4 |
Host-microbe multiomic profiling reveals age-dependent immune dysregulation associated with COVID-19 immunopathology | medRxiv | Hoang Van Phan Alexandra Tstisiklis Cole P Maguire Elias K Haddad Patrice M Becker | 2024 |
Newcastle Disease Virus Vector-Based SARS-CoV-2 Vaccine Candidate AVX/COVID-12 Activates T Cells and Is Recognized by Antibodies from COVID-19 Patients and Vaccinated | bioRxiv | Alejandro Torres-Flores Luis Alberto Ontiveros-Padilla Ruth Lizzeth Madera-Sandoval Araceli Tepale-Segura Julián Gajón-Martínez | 2024 |
The post-COVID-19 population has a high prevalence of cross-reactive antibodies to spikes from all Orthocoronavirinae genera | MBio | Gagandeep Singh Anass Abbad Giulio Kleiner Komal Srivastava Charles Gleason | 2024/1/16 |
Protective effect and molecular mechanisms of human non-neutralizing cross-reactive spike antibodies elicited by SARS-CoV-2 mRNA vaccination | bioRxiv | Jordan Clark Irene Hoxie Daniel Adelsberg Iden Sapse Robert Andreata-Santos | 2024/2/29 |
SARS-CoV-2 infection, inflammation and birth outcomes in a prospective NYC pregnancy cohort | Journal of Reproductive Immunology | Frederieke AJ Gigase Rebecca H Jessel Elianna Kaplowitz Natalie Boychuk Sophie Ohrn | 2024/6/1 |
The immunodominance of antigenic site Sb on the H1 influenza virus hemagglutinin increases with high immunoglobulin titers of the cohorts and with young age, but not sex | Vaccine | Jose L Martínez Nicholas Lemus Tsoi Ying Lai Mitali Mishra Irene González-Domínguez | 2024/4/15 |
IgM N-glycosylation correlates with COVID-19 severity and rate of complement deposition | Nature communications | Benjamin S Haslund-Gourley Kyra Woloszczuk Jintong Hou Jennifer Connors Gina Cusimano | 2024/1/9 |
Co-Authors
